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Abstract - The effects of lipopolysaccharide (LPS) on immune modulation in rats subjected to a right-unilateral lesion of 
the substantia nigra neurons by means of 6-hydroxydopamine (6-OHDA), were investigated. LPS administration (250 µg) 
significantly decreases the total number of leukocytes and erythrocytes, as well as the hemoglobin level in the 6-OHDA-
lesioned rats. In addition, LPS administration was also associated with an increase, relative to control, in the erythrocyte 
indexes and the phagocytosis by neutrophils, and in blastic transformation of T lymphocytes.
The obtained data indicated that LPS exposure might represent a risk factor for the development of the immunological 
changes associated with Parkinson’s disease. 
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INTRODUCTION
Parkinson’s disease (PD) is a neurodegenerative dis-
order characterized by the progressive degeneration 
of  dopaminergic  neurons  in  the  substantia  nigra 
(SN) and the presence of Lewy body inclusions in re-
sidual neurons. In recent years, increasing evidence 
has strongly suggested a role for inflammation in the 
brain in the pathogenesis of PD (Sun et al., 2003). 
Bacterial endotoxin lipopolysaccharide (LPS) is one 
of the common toxins produced by Gram (-) bac-
teria, including Escherichia coli. This agent can elicit 
a multitude of pathophysiological effects, including 
inflammation,  macrophage  activation,  fever,  and 
septic shock (Burrell, 1994, Galanos et al., 1985). The 
blood-brain barrier can become leaky as a result of 
sepsis (Brandtzaeg et al., 1989), allowing LPS to enter 
the cerebrospinal fluid.
Previous studies have demonstrated that bac-
terial LPS exposure, which mimics Gram (-) bac-
terial infections, could cause a significant loss of 
dopamine (DA) neurons in the SN of rat. Along 
with DA neuron loss are the alpha-synuclein posi-
tive Lewy body-like inclusion formation and innate 
immunity dysfunction manifested by an increase in 
the number of reactive microglia, increase in proin-
flammatory cytokine levels, and blood-barrier leak-
age (Ling et al., 2006, Wang et al., 2009). Another 
study  (Calne  and  Langston,  1983)  suggests  that 
acute exposure to LPS killed the DA neurons, but 
the percentage of loss was insufficient to compro-
mise the DA function enough to produce symptom 
expression. However, this cell loss, in conjunction 
with the normal age-related losses of DA neurons, 
would  eventually  lead  to  the  expression  of  PD 
symptoms in the years or decades that followed the 100 L. HRITCU ET AL.
acute exposure. Indeed, numerous DA neurotoxins 
including 6-hydroxydopamine (6-OHDA) (Hritcu 
et al., 2008), rotenone (Sherer et al., 2003), dieldrin 
(Fleming  et  al.,  1994)  and  paraquat  (Koller  and 
Royse, 1986) kill DA neurons in a variety of animal 
models. However, LPS exposure also displayed ad-
ditive or synergetic effects with 6-OHDA (additive) 
or rotenone (synergistic) on DA toxicity (Ling et al., 
2004a, Ling et al., 2004b). Animals exposed to LPS 
exhibit numerous indices of neuroinflammation in 
the nigrostriatal pathway, including life-long eleva-
tions in tumor necrosis factor alpha (TNF-α), in-
creased numbers of activated microglia, increased 
levels of oxidized proteins, and reduced amounts of 
glutathione (GSH) (Herrera et al., 2000, Liu et al., 
2000, Zhu et al., 2007). 
In macrophages and neutrophils, bacteria are 
internalized  through  the  process  of  phagocytosis 
(Lee et al., 2003). Phagocytic cells within the peri-
toneal cavity such as peritoneal macrophages, play 
an important role in the clearance of bacteria and 
bacterial  components  from  the  host  peritoneum 
(Neal et al., 2006, Víctor et al., 1998, Yoshikawa et 
al., 1994).
Recent studies have shown that LPS stimulation 
of murine peritoneal macrophages may be important 
in mediating the functions that are important for 
bacterial killing (Víctor et al., 1998), whereas other 
studies have shown a decrease in phagocytic activ-
ity when macrophages are treated with LPS (Smith 
et al., 1998). 
Therefore, the current study is designed to assess 
whether disordered hematopoiesis regulation via a 
SN neuron lesion is associated with LPS exposure, a 
risk factor for DA neuron loss.
MATERIALS AND METHODS
Subjects
30 male Wistar rats weighing 180 ± 50 g at the start 
of the experiment were used. The animals were 
housed  in  a  temperature-  and  light-controlled 
room (22°C, a 12-h cycle starting at 08:00 h) and 
were fed and allowed to drink water ad libitum. 
The rats were divided into control (15 sham-oper-
ated animals) and LPS+6-OHDA-lesioned rats (15 
animals). The rats were treated in accordance with 
the guidelines of Animal Bioethics from the Act on 
Animal Experimentation and Animal Health and 
Welfare Act of Romania and all procedures were 
in  compliance  with  the  European  Communities 
Council Directive of 24 November 1986 (86/609/
EEC).
Neurosurgery and drug administration
The  rats  were  anesthetized  with  sodium  pento-
barbital (45 mg/kg b.w. i.p., Sigma). The SN was 
right-unilaterally  lesioned  by  stereotaxic  micro-
injections of 8 micrograms (free base) 6-OHDA 
(Sigma),  dissolved  in  4  μl  physiological  saline 
containing 0.1% ascorbic acid (Sigma), adminis-
tered  by  Hamilton  microsyringe  over  4.50  min. 
The syringe was left in place for 5 min after injec-
tion before being slowly removed. The rats were 
pretreated 30 mins before the 6-OHDA infusion 
with 25 mg/kg i.p. desipramine (Sigma) to protect 
noradrenergic  projections.  Sham-operated  rats 
received an injection of desipramine, followed by 
vehicle only in the SN. The following coordinates 
were used: 5.5 mm posterior to bregma; 2.0 mm 
lateral to the midline; 7.4 mm ventral to the sur-
face of the cortex (Paxinos and Watson, 2005). The 
lipopolysaccharide (LPS from Escherichia coli se-
rotype 0111:B4, Sigma) was dissolved in pyrogen-
free 0.9% NaCl to concentrations of 250 µg/kg and 
i.p. injected in the 6-OHDA-lesioned rats over a 
period of 7 consecutive days. 
The hematological parameters, phagocytosis and 
blastic transformation of T lymphocytes were assayed 
after 7 consecutive days of LPS administration. 
Blood sampling protocol
Blood samples were withdrawn via a Biotrol sam-
pling catheter from the 15 sham-operated and 15 
LPS+6-OHDA-lesioned rats. Blood samples (0.5 ml LIPOPOLYSACCHARIDES AND IMMUNOLOGICAL RESPONSE 101
approximately/sample) were collected in vials (Ven-
osafe) containing EDTA for hematological investi-
gations. Hematological parameters were assayed by 
Hematology Analyzer MS9-5 VET Automatic Full 
Digital Cell Counter, Melet Schloesing Laboratoires 
- precision instruments for hematology research. 
Phagocytosis activity of neutrophils
Seven days after continuous LPS administration the 
phagocytic activity of the neutrophils was measured 
from the same blood sample used for the hematolog-
ical parameters assay. The phagocytosis activity was 
performed in vitro following a previously described 
method (Hefco et al., 2004). Briefly, a 100 µl EDTA 
blood sample was mixed with 100 µl of a suspen-
sion  of  Staphylococcus  epidermidis  (4x107/ml)  and 
incubated at 37°C for 30 min with slow stirring (2 
rpm). Smears from the mixture of blood and bacteri-
al culture were May Grünwald-Giemsa stained. The 
phagocytosis activity was calculated as the number 
of bacterial Staphylococcus phagocytized by 100 neu-
trophils. 
Proliferative response of lymphocytes to PHA-M
The proliferative response of lymphocytes to PHA-
M was tested as previously described (Hefco et al., 
2004). The assay was conducted using the same 
blood sample collected for the phagocytic activ-
ity determinantion. In centrifuge tubes (Corning 
TM, FOB Sigma), 75 µl of the EDTA blood sample 
was mixed with 75 µl PHA-M (Sigma) and 5 ml of 
HAM’s medium (Sigma), supplemented with 5% 
heat-inactivated fetal calf serum and 1% antibiotic 
antimicotic solution (Gibco). The final concentra-
tion of PHA-M was 8µg/ml. The tubes were incu-
bated at 37°C in a humidified incubator with 5% 
CO2. After 72 h of incubation, the samples were 
centrifuged at 1200 rpm for 10 min and the super-
natant was removed. Smears were prepared from 
the  sediment  and  were  May  Grünwald-Giemsa 
stained.  Blastoid  and  non-blastoid  lymphocytes 
were counted by an experimenter blind to the treat-
ment group moving along the length of the smear 
from one side to the other, counting throughout 
the entire width, until 100 lymphocytes (blastoid 
and non-blastoid combined). Two slides from each 
sample were counted; their counts were averaged 
and expressed as the percent of lymphocytes that 
were blastoid lymphocytes, the lymphoblast pro-
liferation index.
Histological control
The  rats  were  killed  with  an  overdose  of  sodium 
pentobarbital (100 mg/kg i.p., Sigma) followed by a 
transcardial infusion of 0.9% saline and a 10% for-
malin solution. The brains were removed and placed 
in  a  30%  sucrose/formalin  solution.  Serial  frozen 
sections of 50 μm thickness were cut and stained 
with Cresyl violet for verification of the point of the 
syringe needle. Only experimental data from lesions 
correctly located in the SN were used for statistical 
analysis.
Statistical method
Results  were  analyzed  with  analysis  of  variance 
(ANOVA)  with  the  lesion  as  the  between-groups 
factor (SN and Control). F values for which p<0.05 
were regarded as statistically significant. Number of 
observations was 30.
RESULTS
Histological verification
After the 6-OHDA lesions, the rats recovered quickly 
and gained weight by the first week. In the majority of 
SN-lesioned rats (8/10) the point of the syringe nee-
dle was positioned in the central part of the SN and 
the lesions extended to a part of the adjacent struc-
tures, including the substantia nigra pars reticulata, 
without any significant damage.
Effects of LPS administration on hematological pa-
rameters and the erythrocyte indexes
In the 6-OHDA-lesioned rats, LPS induced a sig-
nificant decrease in the total number of leukocytes 
(F(1,28)=17.27,  p<0.009)  (Fig.  1A),  erythrocytes 102 L. HRITCU ET AL.
(F(1,28)=40.10, p<0.006) (Fig. 1B) and hemoglob-
in  levels  (F(1,28)=19.01,  p<0.01)  (Fig.  1C),  com-
pared  to  the  sham-operated  groups.  Additionally, 
LPS  significantly  increased  the  mean  cell  volume 
(F(1,28)=15, p<0.03) (Fig. 2A), mean cell hemoglob-
in (F(1,28)=22, p<0.02) (Fig. 2B) and mean cell he-
moglobin concentration (F(1,28)=43, p<0.04) (Fig.   
2C) in the 6-OHDA-lesioned rats compared with the 
sham-operated groups. 
Effects of LPS administration on the  
phagocytic activity of neutrophils
In the 6-OHDA-lesioned rats, LPS induced a sig-
nificant  increase  in  the  phagocytic  activity  of  the 
neutrophils (F(1,18)=62.87, p<0.0001) (Fig. 3), com-
pared with the sham-operated group.  
Effects of LPS administration on blastic  
response of T lymphocytes
In the 6-OHDA-lesioned rats, LPS induced a sig-
nificant increase the lymphoblast proliferation index 
(F(1,18)=80.63, p<0.0001) (Fig. 4), compared with 
the sham-operated group. 
DISCUSSION
In  a  previous  study  we  reported  that  the  central 
dopaminergic system has a crucial role in the regu-
lation of the immune processes as well as in hemat-
opoiesis (Hritcu, 2008). Our present study demon-
strated that in 6-OHDA-lesioned rats, exposure to 
LPS induced hematological changes in terms of the 
total white blood cells which support a rapid effect on 
the immune response in rats. A significant decrease 
in total white blood cells was observed 7 days after 
continuous LPS injection in the 6-OHDA-lesioned 
rats. This might be attributable to the massive mi-
gration of these cells to the sites of injection of this 
immunomodulator (Kitajima et al., 1995). Moreo-
ver, the LPS exposure of the 6-OHDA-lesioned rats 
significantly decreased the red blood cell number 
and hemoglobin level. We demonstrated that the 
rats treated with 6-OHDA and exposed to chronic 
LPS showed anemia. Another study suggested that 
nigrostriatal  DA  depletion  rendered  the  animals 
more susceptible to bacterial endotoxin (Engler et 
Fig. 2. a) Variation in MCV (mean cell volume) (*p<0.03 vs. 
sham-operated control group); b) in MCH (mean cell hemoglo-
bin) (*p<0.02 vs. sham-operated control group); c) in MCHC 
(mean cell hemoglobin concentration) (*p<0.04 vs. sham-op-
erated control group) tested after 7 continuous days of LPS ad-
ministration in 6-OHDA-lesioned rats. Values are means ± SEM 
(n=15 per group).
Fig. 1. a) Changes in the total number of leukocytes (*p<0.009 vs. 
sham-operated control group); b) The total number of erythro-
cytes (*p<0.006 vs. sham-operated control group); c) Hemoglo-
bin level (*p<0.01 vs. sham-operated control group) tested after 
7 continuous days of LPS administration in 6-OHDA-lesioned 
rats. Values are means ± SEM (n=15 per group).LIPOPOLYSACCHARIDES AND IMMUNOLOGICAL RESPONSE 103
al., 2009), as is demonstrated by our observation 
in the 6-OHDA-lesioned rats. Some studies found 
marked differences in the distribution and function 
of the blood immune cells of PD patients compared 
to healthy controls, whereas others reported only 
small differences, no differences or even changes in 
the opposite direction (Bas et al., 2001, Reale et al., 
2009). Nevertheless, PD is often complicated with 
infectious diseases and the main causes of death in 
PD patients are pneumonia and respiratory infec-
tions (Hasegawa et al., 2000, Poewe, 2006). In our 
study  we  demonstrated  that  a  substantial  loss  of 
dopaminergic neurons in the nigrostriatal system 
was associated with a significant alteration of hemat-
opoiesis to bacterial LPS exposure. These suggest 
that central dopaminergic hypoactivity contributes 
to an increased susceptibility to infection and mor-
tality in PD patients. Moreover, 6-OHDA-lesioned 
rats displayed an increase in the phagocytic activity 
of neutrophils and the lymphoblast proliferation in-
dex as a result of LPS exposure. 
With regard to phagocytosis, this could be due to 
the activation of neutrophils by LPS injection (Víctor 
et al., 1998). Other data suggested that the chemi-
cal axotomy with 6-OHDA intensifies the prolifera-
tive response of T lymphocytes from spleen (Hefco 
et al., 2004). One mechanism that could explain the 
increased  proliferative  response  involves  catecho-
lamine, which could act through the beta-adrener-
gic receptors located on the T lymphocytes surface 
(Hefco et al., 2004). Therefore we suggest that the in-
creased proliferative response of the T lymphocytes 
in 6-OHDA-lesioned rats exposed to LPS (additive 
effects) is a consequence of a reduction in the sym-
pathetic tone.
In summary, our data suggest that the hemat-
opoiesis and abnormalities after electrolytic lesion 
of the central dopaminergic neurons from the SN 
by means of 6-OHDA are increased following LPS 
exposure.  Additionally,  macrophages  play  a  key 
role  during  LPS  exposure  in  6-OHDA-lesioned 
rats  with  their  most  characteristic  functions, 
showing an increase of the phagocytic process and 
proliferation. 
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Fig. 4. The proliferative response of T peripheral lymphocytes 
to PHA-M tested after 7 continuous days of LPS administration 
in 6-OHDA-lesioned rats. Values are means ± SEM (n=15 per 
group), *p<0.003 vs. sham-operated control group. 
Fig. 3. Phagocytosis activity of neutrophils tested after 7 con-
tinuous days of LPS administration in 6-OHDA-lesioned rats. 
Values are means ± SEM (n=15 per group), *p<0.002 vs. sham-
operated control group. 104 L. HRITCU ET AL.
REFERENCES
Bas, J., Calopa, M., Mestre, M., Mollevi, D.G., Cutillas, B., Ambro-
sio, S. and E. Buendia (2001). Lymphocyte populations in 
Parkinson’s disease and in rat models of Parkinsonism. J 
Neuroimmunol 113, 146-152.
Brandtzaeg, P., Kierulf, P., Gaustad, P., Skulberg, A., Bruun, J.N., 
Halvorsen, S. and E. Sorensen (1989). Plasma endotoxin as 
a predictor of multiple organ failure and death in systemic 
meningococcal disease. J Infect Dis 159, 195-204.
Burrell, R. (1994). Human responses to bacterial endotoxin. Circ 
Shock 43, 137-153.
Calne, D.B. and J.W. Langston (1983). Aetiology of Parkinson’s 
disease. Lancet 2, 1457-1459.
Engler, H., Doenlen, R., Riether, C., Engler, A., Niemi, M.B., Bese-
dovsky, H.O., Rey, A.D., Pacheco-López, G., Feldon, J. and 
M. Schedlowski (2009). Time-dependent alterations of pe-
ripheral immune parameters after nigrostriatal dopamine 
depletion in a rat model of Parkinson’s disease. Brain Be-
hav Immun 23, 518-526.
Fleming, L., Mann, J.B., Bean, J., Briggle, T. and J.R. Sanchez-Ra-
mos (1994). Parkinson’s disease and brain levels of organo-
chlorine pesticides. Ann Neurol 36, 100-103.
Galanos, C., Lüderitz, O., Rietschel, E.T., Westphal, O., Brade, 
H.,  Brade,  L.,  Freudenberg,  M.,  Schade,  U.,  Imoto,  M., 
Yoshimura, H., Kusumoto, S. and T. Shiba (1985). Synthetic 
and natural Escherichia coli free lipid A express identical 
endotoxin activities. Eur J Biochem 148, 1-5.
Hasegawa, Y., Inagaki, T., Sawada, M. and A. Suzumura (2000). 
Impaired cytokine production by peripheral blood mono-
nuclear cells and monocytes/macrophages in Parkinson’s 
disease. Acta Neurol Scand 101, 159-164.
Hefco, V., Olariu, A., Hefco, A. and T. Nabeshima (2004). The 
modulator role of the hypothalamic paraventricular nu-
cleus on immune responsiveness. Brain Behav Immun 18, 
158-165.
Herrera, A.J., Castano, A., Venero, J.L., Cano, G. and A. Machado   
(2000). The single intranigral injection of LPS as a new 
model for studying the selective effects of inflammatory 
reactions on dopaminergic system. Neurobiol Dis 7, 429-
447.
Hritcu,  L.  (2008).  Hematological  disorders  in  6-hydroxydop-
amine-induced rat model of Parkinson’s disease. Turk J 
Hematol 25, 140-144.
Hritcu, L., Ciobica, A. and V. Artenie (2008). Effects of right-
unilateral 6-hydroxydopamine infusion-induced memory 
impairment and oxidative stress: relevance for Parkinson’s 
disease. Cent. Eur. J. Biol. 3, 250-257.
Kitajima, S., Tsuda, M., Eshita, N., Matsushima, Y., Saitoh, M., 
Momma, J. and Y. Kurokawa (1995). Lipopolysaccharide-
associated elevation of serum and urinary nitrite/nitrate 
levels and hematological changes in rats. Toxicol Lett 78, 
135-140.
Koller, W.C. and V.L. Royse (1986). Efficacy of primidone in es-
sential tremor. Neurology 36, 121-124.
Lee, W.L., Harrison, R.E. and S. Grinstein (2003). Phagocytosis 
by neutrophils. Microbes Infect 5, 1299-1306.
Ling, Z., Chang, Q.A., Tong, C.W., Leurgans, S.E., Lipton, J.W. 
and P.M. Carvey (2004a). Rotenone potentiates dopamine 
neuron loss in animals exposed to lipopolysaccharide pre-
natally. Exp Neurol 190, 373-383.
Ling, Z., Zhu, Y., Tong, C., Snyder, J.A., Lipton, J.W. and P.M. 
Carvey (2006). Progressive dopamine neuron loss follow-
ing supra-nigral lipopolysaccharide (LPS) infusion into 
rats exposed to LPS prenatally. Exp Neurol 199, 499-512.
Ling, Z.D., Chang, Q., Lipton, J.W., Tong, C.W., Landers, T.M. and 
P.M. Carvey (2004b). Combined toxicity of prenatal bacte-
rial endotoxin exposure and postnatal 6-hydroxydopamine 
in the adult rat midbrain. Neuroscience 124, 619-628.
Liu, B., Jiang, J.W., Wilson, B.C., Du, L., Yang, S.N., Wang, J.Y., 
Wu, G.C., Cao, X.D. and J.S. Hong (2000). Systemic infu-
sion of naloxane reduces degeneration of rat substantia 
nigral dopaminergic neurons induced by intranigral in-
jection of lipopolysaccharide. J. Pharm. Exp. Ther. 295, 
125-132.
Neal, M.D., Leaphart, C., Levy, R., Prince, J., Billiar, T.R., Watkins, 
S., Li, J., Cetin, S., Ford, H., Schreiber, A. and D.J. Hack-
am (2006). Enterocyte TLR4 mediates phagocytosis and 
translocation of bacteria across the intestinal barrier. J Im-
munol 176, 3070-3079.
Paxinos, G. and S. Watson (2005). The rat brain in stereotaxic 
coordinates, Academic Press, San Diego.
Poewe,  W. (2006). The natural history of Parkinson’s disease. 
Journal of Neurology 253, vii2-vii6.
Reale, M., Iarlori, C., Thomas, A., Gambi, D., Perfetti, B., Di Ni-
cola, M. and M. Onofri (2009). Peripheral cytokines profile 
in Parkinson’s disease. Brain Behav. Immun. 23, 55-63.
Sherer, T.B., Kim, J.H., Betarbet, R. and J.T. Greenamyre (2003). 
Subcutaneous rotenone exposure causes highly selective 
dopaminergic degeneration and alpha-synuclein aggrega-
tion. Exp Neurol 179, 9-16.
Smith, M.E., van der Maesen, K. and F.P. Somera (1998). Mac-
rophage and microglial responses to cytokines in vitro: 
phagocytic activity, proteolytic enzyme release, and free 
radical production. J Neurosci Res 54, 68-78.LIPOPOLYSACCHARIDES AND IMMUNOLOGICAL RESPONSE 105
Sun, S.G., Li, G. and X.B. Cao (2003). Research on relation be-
tween Parkinson disease and inflammatory reaction. Chin 
J Neurol 36, 401.
Víctor, V.M., Miñano, M., Guayerbas, N., Del Río, M., Medina, S. 
and M. De La Fuente  (1998). Effects of endotoxic shock in 
several functions of murine peritoneal macrophages. Moll 
Cell Biochem 189, 25-31.
Wang, S., Yan, J.Y., Lo, Y.K., Carvey, P.M. and Z. Ling (2009). Do-
paminergic and serotoninergic deficiencies in young adult 
rats prenatally exposed to the bacterial lipopolysaccha-
ride. Brain Res 1265, 196-204.
Yoshikawa, T., Takano, H., Takahashi, S., Ichikawa, H. and M. 
Kondo (1994). Changes in tissue antioxidant enzyme ac-
tivities and lipid peroxides in endotoxininduced multiple 
organ failure. Circ Shock 42, 53-58.
Zhu, Y., Carvey, P.M. and Z. Ling (2007). Altered glutathione 
homeostasis in animals prenatally exposed to lipopolysac-
charide. Neurochem Int 50, 671-680.